Help With PPE Supply Chain Disruptions
Severna Pharmaceuticals is committed to assisting hospitals and healthcare systems, as well as, local, State and Federal government agencies with COVID-19 supply chain disruptions across all critical Personnel Protective Equipment (PPE) supplies.
Having a unique concentration on pharmaceuticals, medical devices & supplies prone to shortage, Severna is uniquely positioned to work with qualified suppliers to meet critical demand in a time of crisis.
We Can Help Now
Severna currently has access to SUPPLIER QUALIFIED KN95, N95 & 3PLY MASKS, RAPID ANTIBODY TESTING & PCR DIAGNOSTIC TESTING AND OTHER CRITICAL PPE SUPPLIES.
We have PPE
Access to Resources
Filling unmet demand for critical medicines.
A primary focus on 503b compound & wholesale distribution
Severna Health was formed in 2014 to address continual supply chain disruption felt by hospitals and large healthcare systems nationwide. With a diversified focus on Pharmaceuticals, Laboratory & IVD services- and now Personnel Protective Equipment (PPE)- Severna Health is uniquely positioned to provide reliable solutions during uncertain times.
Our Company Values
Proven strategies with the ability and relationships to make them happen
Severna Health was formed in 2014 to address continual supply chain disruption felt by hospitals and large healthcare systems nationwide. With a diversified focus on Pharmaceuticals, Laboratory & ivd services, and now Personnel Protective Equipment (PPE), Severna Health is uniquely positioned to provide reliable solutions during uncertain times.
A Little Of Our Story
25 years of experience
With executive offices in Annapolis, MD. Severna Health can expedite time to market and eliminate sales operations & associated G&A expenditure while developing significant revenue efficiencies across multiple verticals to accelerate growth. Severna offers immediate access to seasoned sales and service teams, robust client database & existing relationships within the hospital market as an extension to your existing team.
Years of Experience
Experience true business performance increases
We make it simple to launch and scale your therapy.
Focused on addressing drug, testing, and equipment shortages, Severna Health works to improve supply chain deficiencies.
Our candidates are based on existing, well-known active pharmaceutical ingredients (APIs) with established mechanisms of action, safety profiles, and therapeutic activity, avoiding the risks of clinical development and regulatory approval. Our PPE and testing products are American made.
Severna is always exploring FDA filing (NDA & ANDA) opportunities for 503b products through strategic partnerships. We provide access to PPE and testing equipment supply to build robust inventory management.
As a founding member, Scott’s responsibilities focus on business strategy & business plan execution. Scott currently serves as the Chief Executive Officer of Severna Health and Severna Laboratories, an FDA registered repackager & specification developer servicing FDA regulated pharmaceutical & medical device manufacturing, 503B Compounding & Wholesale Distribution. Since founding Severna in 2014, the Company has experienced significant expansion and year-over-year growth.
Before founding Severna, Scott served as Executive Vice President of an FDA regulated 503B Outsourcing Facility, Bryce Laboratories, Inc. Scott’s primary focus was to accelerate growth through a concentration of quality assurance, compliance, product control, & industry diversification.
Scott began his career with American Express Financial Advisors, before becoming Area Manager of Operations for AppleOne, Inc., and later Vice President of Business Development & Account Management for BrainBox Enterprises, Inc., where he oversaw marketing & strategic growth plans for clients such as Magellan Health, Discovery Health, Shire Pharmaceuticals, etc.
Scott has a Bachelor's degree from Hobart College. He and his wife Shannon reside in Annapolis, MD with their two children.
As a founding member, Matt’s responsibilities will focus on sales plan development & execution. Matt currently serves as Chief Revenue Officer of Severna Health, where he is responsible for the day to day sales & performance for Severna. In its sixth year of operations, Matt has Severna pacing to capacity in 2020.
Prior to Severna, Matt was the Executive Vice President of Sales for Pharmagen, Inc., a publicly held Pharmaceutical company focused on the nation’s sterile injectable shortage through independent wholesale distribution & pharmaceutical compounding/ADMIX.
Matt was instrumental in growing two pharmaceutical wholesalers, Global Pharmaceutical Sourcing (GPS) and Premium Rx National (PRN). At GPS, Matt developed the sales infrastructure, training program, and compensation plans while recruiting, hiring, and training 34 representatives generating $81 million in gross revenue within the first five years of operations. Matt’s success at PRN resulted in generated revenues from zero to $14 million within the first twelve months of operation.
Matt is a graduate of the University of Maryland, College Park, with a Bachelor of Arts in Communications. He and his wife reside in Annapolis, MD with their two children.
Andrew’s responsibilities focus on product selection, vendor qualification, regulatory compliance & governance, and clinical development of FDA products.
Andrew has earned a Doctor of Pharmacy and MBA and was pharmacy manager of one of the country’s first FDA-registered compounding outsourcing facilities. There, Andrew aided in the quality assurance of sterile injectables for a variety of patient populations in the tri-state area. Andrew continued to practice sterile compounding and quality assurance at a subsequent 503A pharmacy before joining Geritrex, an OTC pharmaceutical company as the Director of Regulatory Affairs and Head of Quality. He is a certified quality auditor (CQA) through the American Society for Quality (ASQ).
Andrew currently resides in Clark, NJ with his wife and is a valued member of the community.